NitroMed begins BiDil trial

NtroMed (Bedford, Mass.) began the African American Heart Failure Trial (A-HeFT), a 600-patient study designed to

Read the full 164 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE